Background Competing priorities make using a transparent and evidence-based approach
important when deciding to recommend new vaccines. We conducted a literature review to …

Despite the widespread implementation of several effective vaccines over the past few
decades, bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus …

Vaccines have already saved many lives and they have the potential to save many more as
increasingly elaborate technologies deliver new and effective vaccines against both …

As more new and improved vaccines become available, decisions on which to adopt into
routine programmes become more frequent and complex. This qualitative study aimed to …

The decision-making process to introduce new vaccines into national immunization
programmes is often complex, involving many stakeholders who provide technical …

Background: Global health partnerships have grown rapidly in number and scope, yet there
has been less emphasis on their evaluation. Gavi, the Vaccine Alliance, is one such public …

Objectives Lower-middle-income countries (LMICs) are lagging behind both high-income
and low-income countries in new vaccine adoption. Our study involved the following …

Background GAVI's focus on reducing inequities in access to vaccines, immunization, and
GAVI funds,− both between and within countries-has changed over time. This paper charts …

The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries
has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption …

Adoption of new vaccines in developing countries is critical to reducing child mortality and
meeting Millennium Development Goal 4. However, such introduction has historically …